ProQR Therapeutics N.V. (PRQR)

Nasdaq · Pharmaceutical Preparations · Inc. P7

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for ProQR Therapeutics N.V.. Most notable: 2026-07-31: de Boer Daniel Anton (director) bought $354k of stock; 2026-07-09: de Boer Daniel Anton (director) bought $261k of stock; 2026-07-17: Filius Bart (director) bought $258k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Insider purchase
    de Boer Daniel Anton (director) bought $354k of stock
  2. Insider purchase
    Filius Bart (director) bought $258k of stock
  3. Insider purchase
    de Boer Daniel Anton (director) bought $261k of stock
  4. Insider purchase
    de Boer Daniel Anton (director) bought $239k of stock
  5. Insider purchase
    Filius Bart (director) bought $231k of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-07-31de Boer Daniel AntondirectorP200,0001.77$353,960
2026-07-17Filius BartdirectorP150,0001.72$257,925
2026-07-09de Boer Daniel AntondirectorP150,0001.74$261,000
2026-07-07de Boer Daniel AntondirectorP150,0001.59$238,500
2026-06-26Filius BartdirectorP150,0001.54$231,000
2026-06-26Filius BartdirectorP150,0001.54$231,000

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings